These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 15062556

  • 1. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K, Kawada M, Ohba S, Takamoto K, Ishizuka M.
    Mol Cell Endocrinol; 2004 Feb 12; 214(1-2):175-87. PubMed ID: 15062556
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 12; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 3. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S, Agoulnik IU, Weigel NL.
    Prostate; 2005 Sep 01; 64(4):362-72. PubMed ID: 15754350
    [Abstract] [Full Text] [Related]

  • 5. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
    Xie Y, Wolff DW, Lin MF, Tu Y.
    Mol Pharmacol; 2007 Jul 01; 72(1):73-85. PubMed ID: 17430995
    [Abstract] [Full Text] [Related]

  • 6. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.
    Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626
    [Abstract] [Full Text] [Related]

  • 7. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY, Cai C, Fisher CJ, Zheng Z, Omwancha J, Hsieh CL, Shemshedini L.
    Oncogene; 2006 Nov 16; 25(54):7212-23. PubMed ID: 16732317
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.
    Prostate; 2008 Feb 15; 68(3):287-95. PubMed ID: 18163430
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion.
    Sathya G, Chang CY, Kazmin D, Cook CE, McDonnell DP.
    Cancer Res; 2003 Nov 15; 63(22):8029-36. PubMed ID: 14633736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.
    Mashima T, Okabe S, Seimiya H.
    Mol Pharmacol; 2010 Nov 15; 78(5):846-54. PubMed ID: 20709811
    [Abstract] [Full Text] [Related]

  • 13. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S, Wang X, Ng CF, Chen S, Chan FL.
    Cancer Res; 2007 May 15; 67(10):4904-14. PubMed ID: 17510420
    [Abstract] [Full Text] [Related]

  • 14. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 15. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 16. Camptothecin disrupts androgen receptor signaling and suppresses prostate cancer cell growth.
    Liu S, Yuan Y, Okumura Y, Shinkai N, Yamauchi H.
    Biochem Biophys Res Commun; 2010 Apr 02; 394(2):297-302. PubMed ID: 20206136
    [Abstract] [Full Text] [Related]

  • 17. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM, Frazier MC, Harris WB.
    Anticancer Res; 2007 Apr 02; 27(3B):1483-8. PubMed ID: 17595765
    [Abstract] [Full Text] [Related]

  • 18. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
    Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT, Budunova I.
    Cancer Res; 2008 Jun 15; 68(12):4763-73. PubMed ID: 18559523
    [Abstract] [Full Text] [Related]

  • 19. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling.
    Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH.
    Cancer Res; 2004 Dec 15; 64(24):9185-92. PubMed ID: 15604291
    [Abstract] [Full Text] [Related]

  • 20. Repression of androgen receptor mediated transcription by the ErbB-3 binding protein, Ebp1.
    Zhang Y, Fondell JD, Wang Q, Xia X, Cheng A, Lu ML, Hamburger AW.
    Oncogene; 2002 Aug 15; 21(36):5609-18. PubMed ID: 12165860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.